The Clinical Research Unit at The Neuro — one of the largest neurological trial centres in Canada — is celebrating 40 years at the forefront of the cutting-edge therapies with a symposium that brings together international leaders developing the latest generation of treatments.

This day-long event is designed for scientists, health professionals and stakeholders from academia and industry involved in the development of novel therapeutics for rare diseases and offers a unique opportunity to connect with international researchers.

The symposium is a satellite event of the American Society for Human Genetics Annual Meeting (October 20-24) in Montreal, and takes place the day before the start of ASHG proceedings.